Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers

Conditions

• Healthy

Interventions

• DRUG: rhNGF 0.5 µg/mL Sentinel
• DRUG: rhNGF 5 µg/mL Sentinel
• DRUG: rhNGF 20 µg/mL Sentinel
• DRUG: rhNGF 20 µg/mL Part A
• DRUG: rhNGF 60 µg/mL Part A
• DRUG: rhNGF 180 µg/mL Part A
• DRUG: rhNGF 20 µg/mL Part B
• DRUG: rhNGF 60 µg/mL Part B
• DRUG: rhNGF 180 µg/mL Part B
• DRUG: Placebo Part A
• DRUG: Placebo Part B

Sponsor

Dompé Farmaceutici S.p.A

Collaborators

• [object Object]